RIA: Randomized phase II study comparing induction (I) mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and total mesorectal excision (TME) in high risk-rectal cancer. GEMCAD 14-02 trial.
暂无分享，去创建一个
M. Martín | C. Pericay | R. García-Carbonero | J. Capdevila | X. García-Albéniz | R. Vera | J. Gallego | V. Alonso | M. Nogué | F. Losa | A. Salud | J. Maurel | L. Layos | I. Guasch | C. López-López | M. A. Cañas | C. Fernández‐Martos | N. Salas | C. M. Viladot | I. M. Declara